BioMed Research International / 2014 / Article / Fig 3

Research Article

Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia

Figure 3

Time to first treatment (a) and overall survival (b) according to serum sTACI.
159632.fig.003a
(a)
159632.fig.003b
(b)